Molecular Dynamics of Co-signal Molecules in T-Cell Activation
T-cell activation is induced through the TCR microcluster (TCR-MC), which is generated by dynamically recruiting the TCR, kinases, and adaptors to trigger the full activation signal. Co-stimulation receptors also accumulate, mostly at the TCR-MC, and induce signals that positively and negatively modulate the direction and magnitude of T-cell activation. CD28 initially colocalizes with the TCR-MC but then migrates to a distinct region of the cSMAC called the signaling cSMAC, where it recruits and associates with PKCθ, CARMA1, and Rltpr to induce sustained co-stimulation signals leading to NF-kB activation. Although CTLA-4 and PD-1 mediate inhibitory functions in T-cell activation, their molecular dynamics are quite different. Both are expressed only after activation, when they function as feedback inhibition of T-cell activation. Whereas PD-1 initially accumulates in the TCR-MC and then moves to the cSMAC, CTLA-4 directly accumulates at the cSMAC. PD-1 inhibits activation by inducing dephosphorylation of TCR-upstream signaling molecules by transiently recruiting SHP2, whereas CTLA-4 competes with CD28 for CD80/86 binding within the signaling cSMAC. In general, for both positive and negative co-stimulation, these co-stimulation receptors are also clustered in a ligand-dependent fashion, and their colocalization with the TCR-MC is required to mediate co-stimulation signals.
KeywordsImaging TCR signaling Microclusters Immune synapse Co-stimulation CD28 CTLA-4 PD-1
We thank M.L. Dustin, M. Tokunaga, H. Yagita, M. Azuma, and T. Honjo for the collaboration; T. Yokosuka and A. Hashimoto-Tane for the main study; W. Kobayashi, M. Takamatsu, M. Sakuma, and M. Unno for the technical help; and M. Yoshioka and H. Yamaguchi for the secretarial help.
- Harada Y, Ohgai D, Watanabe R, Okano K, Koiwai O, Tanabe K, Toma H, Altman A, Abe R (2003) A single amino acid alteration in cytoplasmic domain determines IL-2 promoter activation by ligation of CD28 but not inducible costimulator (ICOS). J Exp Med 197:257–162PubMedPubMedCentralCrossRefGoogle Scholar
- Lenz G, Davis RE, Ngo VN, Lam L, George TC, Wright GW, Dave SS, Zhao H, Xu W, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Fisher RI, Chan WC, Staudt LM (2008) Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319:1676–1679PubMedCrossRefGoogle Scholar
- Liang Y, Cucchetti M, Roncagalli R, Yokosuka T, Malzac A, Bertosio E, Imbert J, Nijman IJ, Suchanek M, Saito T, Wülfing C, Malissen B, Malissen M (2013) The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nat Immunol 14:858–866PubMedCrossRefGoogle Scholar
- Raab M, Cai YC, Bunnell SC, Heyeck SD, Berg LJ, Rudd CE (1995) p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol-3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T cell costimulation. Proc Natl Acad Sci U S A 92:8891–8895PubMedPubMedCentralCrossRefGoogle Scholar
- Roncagalli R, Cucchetti M, Jarmuzynski N, Grégoire C, Bergot E, Audebert S, Baudelet E, Menoita MG, Joachim A, Durand S, Suchanek M, Fiore F, Zhang L, Liang Y, Camoin L, Malissen M, Malissen B (2016) The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med 213:2437–2457PubMedPubMedCentralCrossRefGoogle Scholar
- Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443–2454PubMedPubMedCentralCrossRefGoogle Scholar
- Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T (2012) Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med 209:1201–1217PubMedPubMedCentralCrossRefGoogle Scholar